The National Academies: Advisers to the Nation on Science, Engineering, and Medicine
NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL
Current Operating Status

The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

Request a Report (Congressional and Government Staff Only)


Mailing Address:
The Office of Congressional and Government Affairs
The Keck Center of the National Academies
Keck WS1008
500 Fifth Street, NW
Washington, DC 20001
Tel: (202) 334-1601
Fax: (202) 334-2419

Back to Main Page

Briefing Date:04/30/2012
Topic:Ethical and Scientific Issues in Studying the Safety of Approved Drugs

THE NATIONAL ACADEMIES
Institute of Medicine
Board on Population Health and Public Health Practice
Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs

*****

Congressional Briefing
Monday, April 30, 2012
428 Dirksen Senate Office Bldg. – 3:30 p.m.

on

Ethical and Scientific Issues in Studying the Safety of Approved Drugs

Though all prescription drugs are tested in clinical trials before they are available to the public, the risks of some drugs may not appear until much later. This new report, from the Institute of Medicine, evaluates the scientific and ethical issues involved in conducting studies of the safety of approved drugs.

This briefing was for members of Congress and congressional staff only. The report was publicly released on May 1, 2012 and can be found, in its entirety, on the Web site of the National Academies Press.

RSS News Feed | Subscribe to e-newsletters | Feedback | Back to Top